Three-year data from ongoing open-label study supported safety and effectiveness of seladelpar in patients with primary biliary cholangitis.

Acute cholangitis, also known as ascending cholangitis, is a serious disorder of the biliary system, which can be life-threatening, if left untreated. The most frequent reason of obstruction of the ...

Data expected H2 2026Rare liver disease with no approved treatment, typically concurrent with Inflammatory Bowel Disease (IBD)Second YAQ001 ...

A pooled analysis of two phase 3 clinical trials shows that the first-in-class drug improves itching and itching-related ...

In medicine, treatment goals set by physicians might differ from patient priorities. Although normalisation of laboratory parameters is a target supported by outcomes data, patient perspectives ...

Ahmad Anouti, MD, a pediatric resident at UT Southwestern Medical Center, spoke about the current treatment landscape for ...

A: Cholangitis refers to inflammation of the bile ducts. This is mostly caused by bacteria because of blockage of the bile duct. It can spread to the liver. A: Liver transplantation increases the ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced new long-term data reinforcing the safety and efficacy profile of ...

Primary biliary cholangitis (PBC) is a chronic progressive autoimmune disorder characterized by small non-purulent ...

This page lists all known medications that could potentially lead to 'Cholangitis sclerosing' as a side effect. It's important to note that mild side effects are quite common with medications. The ...